Reverberations for Ebos in Chemist Warehouse reverse listing

Reverberations for Ebos in Chemist Warehouse reverse listing
Sigma shareholders might well ask themselves if they're paying too much. (Image: NZME)
Paul McBeth
Discount pharmacist Chemist Warehouse’s reverse takeover of drugmaker Sigma Healthcare to build Australia’s biggest pharmacy group won’t immediately dent Ebos Group and may even offer some opportunities down the road. The discount pharmacist found its route onto the Australian securities exchange (ASX) via a reverse listing of Sigma, where Sigma will borrow A$1 billion (NZ$1.07b) from ANZ and National Australia Bank, give A$700m of that to the Chemist Warehouse shareholders and issue them shares equivalent to 85.8% of the...

More Markets

Market up despite a2 demotion and Restaurant Brands bid
Markets Market Close

Market up despite a2 demotion and Restaurant Brands bid

The S&P/NZX 50 Index closed up 0.23% or 30.41 points to 13,307.40.

Jarden downgrades A2 Milk to underweight
Primary Sector

Jarden downgrades A2 Milk to underweight

Analysts nudge up their 12-month target price for A2 to $7.85 from $7.80.

Sharesies unleashes crypto coins on platform
Finance

Sharesies unleashes crypto coins on platform

The average spend during the beta launch has been about $1,000.

Comvita's survival 'uncertain' if shareholders reject takeover bid
Markets

Comvita's survival 'uncertain' if shareholders reject takeover bid

The board says there is no better offer on the table than the one from Florenz.